Research collaborations
Garvan drives a number of collaborative programs with scientific and medical institutes globally.
CIRCA
The Clinical Immunogenomics Research Consortium Australasia uses genomics to inform diagnosis and treatment for complex immunological diseases
Australian Parkinson's Mission
A five-year, international collaborative program for Parkinson’s disease, integrating clinical trials with potentially transformative genomic analysis and biomarkers research.
Hope Research
A radical program to understand autoimmune disease. Our researchers think there may be a common cause to type 1 diabetes, multiple sclerosis, lupus and rheumatoid arthritis.
Exceptional Responders Program
A collaborative study of those who have exceptional responses to cancer treatment — and using this knowledge to help others with the disease.
Genomic Cancer Medicine Program
This program is dedicated to using genomics to improve the understanding, early detection, prevention and management of cancer.
AVaTAR
AVaTAR is a unique translational consortium to provide improved, rapid pre-clinical vaccine candidate evaluation.
